Paradigm Capital Management LLC NV purchased a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 28,084 shares of the company’s stock, valued at approximately $3,609,000. Merck KGaA accounts for about 3.1% of Paradigm Capital Management LLC NV’s portfolio, making the stock its 7th biggest holding.
Several other hedge funds have also added to or reduced their stakes in the company. Front Street Capital Management Inc. bought a new stake in Merck KGaA during the 2nd quarter worth about $218,000. Womack Financial LLC acquired a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $689,000. Peak Asset Management LLC bought a new stake in shares of Merck KGaA during the second quarter worth approximately $2,767,000. Fiduciary Financial Advisors acquired a new position in Merck KGaA in the second quarter valued at approximately $295,000. Finally, Manning & Napier Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at approximately $22,484,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
MKGAF opened at $163.45 on Tuesday. The company has a fifty day moving average price of $162.78 and a two-hundred day moving average price of $148.59. The firm has a market capitalization of $21.12 billion, a PE ratio of 24.95 and a beta of 0.96. Merck KGaA has a 52 week low of $116.68 and a 52 week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
